BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1853270)

  • 1. [Markers of hypercoagulability during pregnancy: thrombin-antithrombin-III complexes and D dimer].
    Senent M; Bellart J; Zuazu-Jausoro I; Oliver A; Montserrat I; Ribera L; Tirado I; Cabero L; Fontcuberta J
    Sangre (Barc); 1991 Feb; 36(1):21-4. PubMed ID: 1853270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women.
    Bombeli T; Raddatz-Mueller P; Fehr J
    Am J Obstet Gynecol; 2001 Feb; 184(3):382-9. PubMed ID: 11228491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A trial of setting of the reference intervals of thrombin antithrombin III complex and fibrin.fibrinogen degradation products in pregnant women].
    Shizuka R; Amagai H; Kojima J; Imaizumi S; Fukumura Y; Kobayashi I; Takagi T; Ibuki Y
    Rinsho Byori; 1994 Nov; 42(11):1194-8. PubMed ID: 7844893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced thrombin generation and fibrinolytic activity in normal pregnancy and the puerperium.
    Bremme K; Ostlund E; Almqvist I; Heinonen K; Blombäck M
    Obstet Gynecol; 1992 Jul; 80(1):132-7. PubMed ID: 1534880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of prophylactic heparin treatment on enhanced thrombin generation in pregnancy.
    Bremme K; Lind H; Blombäck M
    Obstet Gynecol; 1993 Jan; 81(1):78-83. PubMed ID: 8416465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of thrombin-antithrombin complexes in hypercoagulability conditions. Analysis of 182 cases].
    Zuazu-Jausoro I; Borrell M; Urrutia T; Oliver A; Montserrat I; Mateo J; Ribera L; Fontcuberta J
    Sangre (Barc); 1990 Oct; 35(5):375-9. PubMed ID: 2291147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue plasminogen activator levels change with plasma fibrinogen concentrations during pregnancy.
    Choi JW; Pai SH
    Ann Hematol; 2002 Nov; 81(11):611-5. PubMed ID: 12454697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinogen, D-dimer and thrombin-antithrombin complexes in a random population sample: relationships with other cardiovascular risk factors.
    Giansante C; Fiotti N; Cattin L; Da Col PG; Calabrese S
    Thromb Haemost; 1994 May; 71(5):581-6. PubMed ID: 8091384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of D-dimer during pregnancy.
    Nishii A; Noda Y; Nemoto R; Ushiro K; Ohno T; Mochizuki Y; Yoshihara H; Taguchi A; Uchino N; Ohkawara S
    J Obstet Gynaecol Res; 2009 Aug; 35(4):689-93. PubMed ID: 19751328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrin monomer complex in normal pregnant women: a potential thrombotic marker in pregnancy.
    Onishi H; Kaniyu K; Iwashita M; Tanaka A; Watanabe T
    Ann Clin Biochem; 2007 Sep; 44(Pt 5):449-54. PubMed ID: 17761030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased thrombin generation in normal pregnancy.
    Pinto S; Abbate R; Rostagno C; Bruni V; Rosati D; Neri Serneri GG
    Acta Eur Fertil; 1988; 19(5):263-7. PubMed ID: 3252655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemostasis in normal pregnancy.
    Stirling Y; Woolf L; North WR; Seghatchian MJ; Meade TW
    Thromb Haemost; 1984 Oct; 52(2):176-82. PubMed ID: 6084322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TAT, F1 + 2, and D-dimer levels in patients after coronary angiography with nonionic or ionic contrast media or after cardiac catheterization.
    Biancardi M; Cimminiello C; Toschi V; Schiavina G; Regalia F; Casolo F; Bonfardeci G
    Semin Thromb Hemost; 1996; 22 Suppl 1():61-5. PubMed ID: 8807731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between grade III placenta and plasma antithrombin III activity in full term pregnancy.
    Asakura H; Ohshita T; Suzuki S; Araki T
    Gynecol Obstet Invest; 2001; 52(1):47-50. PubMed ID: 11549864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-dimer and thrombin-antithrombin III complex levels uncorrelated with phlebographic findings in 11 total knee replacement patients.
    De Prost D; Ollivier V; Vie P; Benacerraf R; Duparc J; Khoury A
    Ann Biol Clin (Paris); 1990; 48(4):235-8. PubMed ID: 2193559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The predictive value of the hemostasis parameters in the development of preeclampsia.
    Ho CH; Yang ZL
    Thromb Haemost; 1992 Feb; 67(2):214-8. PubMed ID: 1621241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation-fibrinolysis is more enhanced in twin than in singleton pregnancies.
    Morikawa M; Yamada T; Turuga N; Cho K; Yamada H; Sakuragi N; Minakami H
    J Perinat Med; 2006; 34(5):392-7. PubMed ID: 16965226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden.
    Eichinger S; Weltermann A; Philipp K; Hafner E; Kaider A; Kittl EM; Brenner B; Mannhalter C; Lechner K; Kyrle PA
    Thromb Haemost; 1999 Oct; 82(4):1232-6. PubMed ID: 10544904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of long term oral anticoagulants upon prothrombin fragment 1 + 2, thrombin-antithrombin III complex and D-Dimer levels in patients affected by proximal deep vein thrombosis.
    Elias A; Bonfils S; Daoud-Elias M; Gauthier B; Sié P; Boccalon H; Boneu B
    Thromb Haemost; 1993 Apr; 69(4):302-5. PubMed ID: 8497840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypercoagulability during pregnancy: evidences for a thrombophilic state].
    Maiello M; Torella M; Caserta L; Caserta R; Sessa M; Tagliaferri A; Bernacchi M; Napolitano M; Nappo C; De Lucia D; Panariello S
    Minerva Ginecol; 2006 Oct; 58(5):417-22. PubMed ID: 17006429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.